Literature DB >> 11724913

Mechanisms of neurodegeneration in amyotrophic lateral sclerosis.

S Cluskey1, D B Ramsden.   

Abstract

Amyotrophic lateral sclerosis (ALS) is the most common variant of motor neurone disease affecting adults that usually strikes during mid to late life. Its aetiology is still poorly understood, although a major breakthrough came with the discovery that mutations in the Cu/Zn superoxide dismutase (SOD1) gene affect approximately 20% of patients with familial ALS. Experiments using both transgenic mice and ALS tissues have been useful in delineating other genetic defects in ALS. However, because only a subset of cases can be attributed to one particular molecular defect (such as mutation of SOD1 or the gene encoding neurofilament H), the aetiology of ALS is likely to be multifactorial. This review discusses the major mechanisms of neurodegeneration in ALS, such as oxidative stress, glutaminergic excitotoxicity, damage to vital organelles, and aberrant protein aggregation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11724913      PMCID: PMC1187128     

Source DB:  PubMed          Journal:  Mol Pathol        ISSN: 1366-8714


  62 in total

Review 1.  Oxidative stress in amyotrophic lateral sclerosis.

Authors:  W Robberecht
Journal:  J Neurol       Date:  2000-03       Impact factor: 4.849

Review 2.  What transgenic mice tell us about neurodegenerative disease.

Authors:  M E Gurney
Journal:  Bioessays       Date:  2000-03       Impact factor: 4.345

3.  The RNA of the glutamate transporter EAAT2 is variably spliced in amyotrophic lateral sclerosis and normal individuals.

Authors:  T Meyer; A Fromm; C Münch; B Schwalenstöcker; A E Fray; P G Ince; S Stamm; G Grön; A C Ludolph; P J Shaw
Journal:  J Neurol Sci       Date:  1999-11-15       Impact factor: 3.181

4.  Polymorphisms in the glutamate transporter gene EAAT2 in European ALS patients.

Authors:  M Jackson; G Steers; P N Leigh; K E Morrison
Journal:  J Neurol       Date:  1999-12       Impact factor: 4.849

5.  Prevention of mutant SOD1 motoneuron degeneration by copper chelators in vitro.

Authors:  M Azzouz; P Poindron; S Guettier; N Leclerc; C Andres; J M Warter; J Borg
Journal:  J Neurobiol       Date:  2000-01

6.  Immunocytochemical study on the distribution of nitrotyrosine in the brain of the transgenic mice expressing a human Cu/Zn SOD mutation.

Authors:  C I Cha; Y H Chung; C M Shin; D H Shin; Y S Kim; M E Gurney; K W Lee
Journal:  Brain Res       Date:  2000-01-17       Impact factor: 3.252

7.  Astrocytes interact intimately with degenerating motor neurons in mouse amyotrophic lateral sclerosis (ALS).

Authors:  J B Levine; J Kong; M Nadler; Z Xu
Journal:  Glia       Date:  1999-12       Impact factor: 7.452

Review 8.  Molecular factors underlying selective vulnerability of motor neurons to neurodegeneration in amyotrophic lateral sclerosis.

Authors:  P J Shaw; C J Eggett
Journal:  J Neurol       Date:  2000-03       Impact factor: 4.849

Review 9.  The role of excitotoxicity in ALS--what is the evidence?

Authors:  A C Ludolph; T Meyer; M W Riepe
Journal:  J Neurol       Date:  2000-03       Impact factor: 4.849

Review 10.  Mechanisms for neuronal degeneration in amyotrophic lateral sclerosis and in models of motor neuron death (Review).

Authors:  L J Martin; A C Price; A Kaiser; A Y Shaikh; Z Liu
Journal:  Int J Mol Med       Date:  2000-01       Impact factor: 4.101

View more
  49 in total

Review 1.  Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders.

Authors:  Mark P Mattson
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 3.843

2.  Human cells from cloned embryos in research and therapy.

Authors:  Ian Wilmut
Journal:  BMJ       Date:  2004-02-21

3.  In vivo voxel-based relaxometry in amyotrophic lateral sclerosis.

Authors:  Martina Minnerop; Karsten Specht; Jürgen Ruhlmann; Christoph Grothe; Ullrich Wüllner; Thomas Klockgether
Journal:  J Neurol       Date:  2009-02-16       Impact factor: 4.849

4.  AxCaliber: a method for measuring axon diameter distribution from diffusion MRI.

Authors:  Yaniv Assaf; Tamar Blumenfeld-Katzir; Yossi Yovel; Peter J Basser
Journal:  Magn Reson Med       Date:  2008-06       Impact factor: 4.668

5.  Nonparametric pore size distribution using d-PFG: comparison to s-PFG and migration to MRI.

Authors:  Dan Benjamini; Michal E Komlosh; Peter J Basser; Uri Nevo
Journal:  J Magn Reson       Date:  2014-06-30       Impact factor: 2.229

6.  Inferring diameters of spheres and cylinders using interstitial water.

Authors:  Sheryl L Herrera; Morgan E Mercredi; Richard Buist; Melanie Martin
Journal:  MAGMA       Date:  2018-06-04       Impact factor: 2.310

Review 7.  Need for a paradigm shift in therapeutic approaches to CNS injury.

Authors:  Bharath Wootla; Aleksandar Denic; Arthur E Warrington; Moses Rodriguez
Journal:  Expert Rev Neurother       Date:  2012-04       Impact factor: 4.618

8.  Tissue microstructure features derived from anomalous diffusion measurements in magnetic resonance imaging.

Authors:  Qiang Yu; David Reutens; Kieran O'Brien; Viktor Vegh
Journal:  Hum Brain Mapp       Date:  2016-10-18       Impact factor: 5.038

9.  The impact of gradient strength on in vivo diffusion MRI estimates of axon diameter.

Authors:  Susie Y Huang; Aapo Nummenmaa; Thomas Witzel; Tanguy Duval; Julien Cohen-Adad; Lawrence L Wald; Jennifer A McNab
Journal:  Neuroimage       Date:  2014-12-09       Impact factor: 6.556

10.  The Human Connectome Project and beyond: initial applications of 300 mT/m gradients.

Authors:  Jennifer A McNab; Brian L Edlow; Thomas Witzel; Susie Y Huang; Himanshu Bhat; Keith Heberlein; Thorsten Feiweier; Kecheng Liu; Boris Keil; Julien Cohen-Adad; M Dylan Tisdall; Rebecca D Folkerth; Hannah C Kinney; Lawrence L Wald
Journal:  Neuroimage       Date:  2013-05-24       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.